Long lead-times involved in medical device contract sterilization force companies to assemble large batches of product before they can be processed for sterilization. These large batches add other negative effects to processing such as significant transportation costs, greater work-in-process (WIP) inventory, and delayed customer shipments. As a result, medical manufacturers are constantly looking for ways to improve their production efficiency. This white paper discusses the challenges of contract sterilization in the case of MEDIVATORS, and how they used REVOX for an alternative sterilization process. Download the full paper to learn more about how REVOX was able to help this medical company break free from batch processing.